Life Tech Will No Longer Report Mass-Spec Sales Figures, Which Slid 17 Percent in Q4 | GenomeWeb

Amid a 17 percent slide in its mass-spectrometry business during the final three months of 2008, Life Technologies said last week it will no longer include revenues from that division as part of the company's total revenues.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.